Back to 
ING Groep N.V.
ING Groep N.V.
TXG
Showing 4 of 6 quarters
Position history for ING Groep N.V.'s holdings in 10x Genomics, Inc.
No. ING Groep exited its TXG (10x Genomics) position in Q3 2025. Its Q2 2025 13F listed 286,500 shares worth $3.3M. ING Groep first reported TXG in Q1 2024 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.1M
Total Shares Change
-75,400
Quarter-by-Quarter History
Other major holders of TXG: FMR LLC